SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Sep 13, 2017
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Sept. 13, 2017 · CIK: 0001585608 · Accession: 0001104659-17-056940
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220236
Letter
Re: Jaguar Health, Inc. Registration Statement on Form S-3 File No. 333-220236
September 13, 2017
Via Email and EDGAR
Jeffrey Gabor U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549
Ladies and Gentlemen:
Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on September 14, 2017, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable.
Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.
Very truly yours,
Jaguar Health, Inc.
Show Raw Text
CORRESP 1 filename1.htm September 13, 2017 Via Email and EDGAR Jeffrey Gabor U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Health, Inc. Registration Statement on Form S-3 File No. 333-220236 Ladies and Gentlemen: Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on September 14, 2017, at 4:00 p.m., Eastern Daylight Time, or as soon thereafter as is practicable. Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358. Very truly yours, Jaguar Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105 Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health